Colorectal cancer (CRC) treatment in 871 Oncology clinics worldwide

Top
Clinics
Ratings
Diseases
More info
Quick navigation

871 clinics specializing in Oncology providing treatment of Colorectal cancer (CRC) Colorectal cancer (CRC) is a type of cancer that starts in the colon or rectum. It can cause changes in bowel habits, rectal bleeding, and may require surgery, chemotherapy, or radiation therapy for treatment and prevention of spread.
Read more...
disease worldwide.

Africa · 14
Americas · 181
Asia · 264
Europe · 370
Oceania · 42
You can select a specific region
Africa · 14 Americas · 181 Asia · 264 Europe · 370 Oceania · 42
Sorted by:
Relevance
Rating Relevance
Prices for popular procedures:
  1. Targeted therapy
    by request
  2. Chemotherapy for colorectal cancer
    by request
  3. Chemotherapy for melanoma
    by request
  4. Chemotherapy for endometrial cancer
    by request
  5. Chemotherapy for gallbladder cancer
    by request
  6. Chemotherapy for bone cancer
    by request
  7. Chemotherapy for eye cancer
    by request
  8. Chemotherapy for myeloma
    by request
  9. Chemotherapy for non-melanoma skin cancer
    by request
photo
Belo Horizonte, Brazil
Specializations: Oncology
Founded in 1999, Oncocentro was born with the purpose of offering an integral, welcoming and interdisciplinary service. Over the years, it has become a reference read more
Prices for popular procedures:
  1. Intensity-modulated radiation therapy (IMRT)
    $2,145 - $3,244
  2. Volumetric modulated arc therapy (VMAT)
    $2,145 - $3,244
  3. Image-guided radiation therapy (IGRT)
    $2,145 - $3,244
  4. Stereotactic radiation therapy (SRT)
    $2,310
  5. Radiosurgery
    $2,310 - $3,354
  6. CyberKnife radiosurgery
    $2,310 - $3,354
  7. Stereotactic spine radiosurgery
    $2,145 - $2,420
photo
Ufa, Russia
Specializations: Oncology
The center has equipment for PET / CT examinations from one of the leaders in the production of medical equipment. The same equipment is used read more
Prices for popular procedures:
  1. Radiation therapy
    $2,200
  2. Radiotherapy for rectal cancer
    $2,200
  3. Intensity-modulated radiation therapy (IMRT)
    $2,200
  4. Volumetric modulated arc therapy (VMAT)
    by request
  5. Chemotherapy for colorectal cancer
    by request
  6. Radiation therapy for breast cancer
    $1,870 - $3,299
  7. Radiotherapy for prostate cancer
    $2,200
  8. LINAC based stereotactic radiosurgery
    $2,200
  9. Stereotactic radiation therapy (SRT)
    $2,200
photo
Balashikha, Russia
Specializations: Oncology
The PET-Technology oncology center in Balashikha was designed, built and equipped as part of a public-private partnership with the Government of the Moscow Region, the read more
Prices for popular procedures:
  1. Radiation therapy
    $2,200
  2. Radiotherapy for rectal cancer
    $2,200
  3. Intensity-modulated radiation therapy (IMRT)
    $2,200
  4. Volumetric modulated arc therapy (VMAT)
    by request
  5. Chemotherapy for colorectal cancer
    by request
  6. Radiation therapy for breast cancer
    $1,870 - $3,299
  7. Radiotherapy for prostate cancer
    $2,200
  8. LINAC based stereotactic radiosurgery
    $2,200
  9. Stereotactic radiation therapy (SRT)
    $2,200
photo
Podolsk, Russia
Specializations: Oncology
The PET-Technology Cancer Radiology Center in Podolsk is a modern, comfortable medical facility for patients with any stage of the disease. The center has a read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $2,131
  2. Total colectomy
    ≈ $1,378
  3. Proctocolectomy
    ≈ $2,646
  4. Hartmann's operation
    ≈ $856
  5. Sigmoidectomy
    ≈ $1,669
  6. Rectum anterior resection
    ≈ $1,115
  7. Conization
    ≈ $1,046
  8. Open hysterectomy
    ≈ $1,605
  9. Loop electrosurgical excision procedure (LEEP)
    $189
photo
Riga, Latvia
Specializations: Thoracic surgery, Oncology
Our highly qualified specialists have experience in clinical and scientific work. We use laparoscopic operations in the surgical treatment of ovarian cysts, fibroids, uterus read more
Prices for popular procedures:
  1. Targeted therapy
    by request
  2. Chemotherapy for colorectal cancer
    by request
  3. Chemotherapy for liver cancer
    by request
  4. Chemotherapy for brain cancer
    by request
  5. Chemotherapy for lymphoma
    by request
  6. Chemotherapy for gallbladder cancer
    by request
  7. Chemotherapy for eye cancer
    by request
  8. Chemotherapy for myeloma
    by request
  9. Chemotherapy for melanoma
    by request
photo
Budapest, Hungary
Specializations: Oncology
In the Oncology Profile of the Internal Medicine and Oncology Clinic patients with so-called solid tumors are treated with medication. The center offers traditional chemotherapy read more
Prices for popular procedures:
  1. Radiation therapy
    by request
  2. Chemotherapy for colorectal cancer
    by request
  3. Radiation therapy for breast cancer
    from $20,564
  4. Radiotherapy for prostate cancer
    from $32,596
  5. Brachytherapy for prostate cancer
    from $50,172
  6. Simple mastectomy
    from $15,993
  7. Lumpectomy
    ≈ $6,670
  8. Partial mastectomy
    from $18,144
  9. Radical mastectomy
    from $15,993
photo
Helsinki, Finland
Specializations: Oncology
Docrates Cancer Center, based in Helsinki, Finland, is a leading international treatment facility specialising in the diagnostics, treatment and follow-up of cancers. The hospital opened read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $19,727
  2. Total colectomy
    ≈ $15,440
  3. Proctocolectomy
    ≈ $24,776
  4. Hartmann's operation
    ≈ $13,362
  5. Sigmoidectomy
    ≈ $16,555
  6. Rectum anterior resection
    ≈ $16,780
  7. Targeted therapy
    by request
  8. Radiation therapy
    by request
  9. Intensity-modulated radiation therapy (IMRT)
    by request
photo
Dubai, United Arab Emirates
Specializations: Thoracic surgery, Oncology
Languages: English, Arabic
Mediclinic City Hospital’s Comprehensive Cancer Centre (CCC), is Dubai’s most advanced facility for the diagnosis and treatment of cancer. Built in collaboration with Mediclinic Middle read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $9,562
  2. Total colectomy
    ≈ $7,352
  3. Proctocolectomy
    ≈ $15,997
  4. Hartmann's operation
    ≈ $7,183
  5. Sigmoidectomy
    ≈ $6,283
  6. Rectum anterior resection
    ≈ $6,779
  7. Targeted therapy
    by request
  8. Radiation therapy
    by request
  9. Chemotherapy for colorectal cancer
    by request
photo
Medina, Saudi Arabia
Specializations: Vascular surgery, Thoracic surgery, Oncology
King Faisal Specialist Hospital & Research Centre (Gen. Org) Madinah (KFSH&RC-M) is the latest addition to our internationally recognized organization. Our mission at KFSH&RC-M is read more
Prices for popular procedures:
  1. Targeted therapy
    by request
  2. Radiation therapy
    by request
  3. Volumetric modulated arc therapy (VMAT)
    by request
  4. Intraoperative radiotherapy
    by request
  5. Four-Dimensional Radiotherapy (4DRT)
    by request
  6. Radical prostatectomy
    ≈ $15,919
  7. Transurethral resection of the prostate (TURP)
    ≈ $7,542
  8. Conization
    ≈ $3,272
  9. Open hysterectomy
    ≈ $5,053
photo
Toulouse, France
Specializations: Thoracic surgery, Oncology
Languages: English, German, Spanish; Castilian
The IUCT Oncopole comprises the Institut Claudius Regaud, a cancer center, and several teams from Toulouse University Hospital Center. The two institutions offer the expertise read more
Prices for popular procedures:
  1. Radiation therapy
    by request
  2. Chimeric antigen receptor (CAR) T-cell therapy
    by request
  3. Immune checkpoint inhibitors
    by request
  4. Monoclonal antibodies therapy (mAbs)
    by request
  5. Natural killer (NK) cell therapy
    by request
photo
São Paulo, Brazil
Specializations: Oncology
Occupying a total area of ​​1,550 m2, we have an infrastructure specially built to ensure the well-being of patients during cancer treatment. Humanism was the read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $25,611
  2. Total colectomy
    ≈ $22,047
  3. Proctocolectomy
    ≈ $42,507
  4. Hartmann's operation
    ≈ $21,898
  5. Sigmoidectomy
    ≈ $21,539
  6. Rectum anterior resection
    ≈ $21,585
  7. Chemotherapy for colorectal cancer
    by request
  8. Laparoscopic cholecystectomy
    ≈ $9,425
  9. Total gastrectomy
    ≈ $40,937
photo
London, United Kingdom
Specializations: Cardiac surgery, Thoracic surgery, Oncology
Newsweek ranks Mayo Clinic in the United States as the best hospital in the world. U.S. News & World Report has ranked it No. 1 read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $21,648
  2. Total colectomy
    ≈ $18,318
  3. Proctocolectomy
    ≈ $15,594
  4. Hartmann's operation
    ≈ $9,618
  5. Sigmoidectomy
    ≈ $16,839
  6. Rectum anterior resection
    ≈ $21,085
  7. Robot-assisted oncosurgery
    by request
  8. Radiation therapy
    by request
  9. Chemotherapy for colorectal cancer
    by request
photo
Milan, Italy
Specializations: Cardiac surgery, Vascular surgery, Thoracic surgery, Oncology
Languages: Arabic, English, Russian
The IEO (European Institute of Oncology) is one of the world's most prestigious hospitals and the fastest growing comprehensive cancer centre in Europe. IEO integrates read more
Prices for popular procedures:
  1. Hemicolectomy
    $1,211 - $2,109
  2. Total colectomy
    $1,211 - $2,109
  3. Proctocolectomy
    ≈ $1,795
  4. Hartmann's operation
    ≈ $832
  5. Sigmoidectomy
    ≈ $1,855
  6. Rectum anterior resection
    $1,211 - $2,109
  7. Targeted therapy
    by request
  8. Radiation therapy
    $170 - $6,092
  9. Chemotherapy for colorectal cancer
    by request
photo
Kazan, Russia
Specializations: Cardiac surgery, Vascular surgery, Thoracic surgery, Oncology
GAUZ "Republican Clinical Oncological Dispensary of the Ministry of Health of the Republic of Tatarstan" named after Professor M.Z. Sigal "is one of the largest read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $16,371
  2. Total colectomy
    ≈ $17,051
  3. Proctocolectomy
    ≈ $8,569
  4. Hartmann's operation
    ≈ $4,724
  5. Sigmoidectomy
    ≈ $9,092
  6. Rectum anterior resection
    ≈ $17,788
  7. Robot-assisted oncosurgery
    by request
  8. Robotic surgery for colorectal cancer
    ≈ $25,176
  9. Targeted therapy
    by request
photo
Marseille, France
Specializations: Vascular surgery, Thoracic surgery, Oncology
The Paoli-Calmettes Institute (IPC) is a center for the fight against cancer, a member of the Unicancer group , governed by the public health code. read more
Prices for popular procedures:
  1. Chemotherapy for colorectal cancer
    by request
  2. Conization
    ≈ $2,035
  3. Open hysterectomy
    ≈ $2,470
  4. Loop electrosurgical excision procedure (LEEP)
    ≈ $1,134
  5. Total laparoscopic hysterectomy (TLH)
    $1,497
  6. Laparoscopic cholecystectomy
    ≈ $1,460
  7. Total gastrectomy
    ≈ $18,280
  8. Total thyroidectomy
    ≈ $4,695
  9. Cholecystectomy
    ≈ $2,997
photo
Reynosa, Mexico
Specializations: Cardiac surgery, Vascular surgery, Oncology
Languages: English
The quality of CHRISTUS MUGUERZA on the Mexican border At CHRISTUS MUGUERZA Hospital Reynosa we provide high quality medical services to the Tamaulipas border community read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $4,521
  2. Total colectomy
    ≈ $3,446
  3. Proctocolectomy
    ≈ $6,296
  4. Hartmann's operation
    ≈ $3,247
  5. Sigmoidectomy
    ≈ $3,248
  6. Rectum anterior resection
    ≈ $3,505
  7. Chemotherapy for colorectal cancer
    by request
  8. Conization
    ≈ $735
  9. Open hysterectomy
    ≈ $1,640
photo
Chittagong, Bangladesh
Specializations: Thoracic surgery, Oncology
Chattogram Maa-O-Shishu Hospital is a 650-bedded hospital, which includes Paediatrics Medicine, Neonatology, Pediatric Surgery, Paediatric Neorology, General Surgery, Obstetrics & Gynaecology, Medicine & it's sub-specialists. read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $6,481
  2. Total colectomy
    ≈ $5,335
  3. Proctocolectomy
    ≈ $7,365
  4. Hartmann's operation
    ≈ $4,044
  5. Sigmoidectomy
    ≈ $6,777
  6. Rectum anterior resection
    ≈ $6,777
  7. Radical prostatectomy
    ≈ $6,161
  8. Transurethral resection of the prostate (TURP)
    ≈ $2,308
  9. Conization
    ≈ $725
photo
Esztergom, Hungary
Specializations: Orthopedic surgery, Oncology
Languages: English, German
The Vaszary Kolos Hospital is more than 100 years old, pavilion system, in the eastern corner of Komárom-Esztergom county, 46 km from Budapest. It is read more
Prices for popular procedures:
  1. Targeted therapy
    by request
  2. Radiation therapy
    by request
  3. Intensity-modulated radiation therapy (IMRT)
    by request
  4. Volumetric modulated arc therapy (VMAT)
    by request
  5. Chemotherapy for colorectal cancer
    by request
  6. Radical prostatectomy
    ≈ $10,167
  7. Transurethral resection of the prostate (TURP)
    ≈ $3,127
  8. Radical nephrectomy
    ≈ $6,052
  9. Parotidectomy
    ≈ $1,171
photo
Chennai, India
Specializations: Thoracic surgery, Orthopedic surgery, Oncology
The Cancer Institute (WIA), as you are aware, is a public charitable voluntary institute dedicated to the care of cancer for for the last 60 read more
Prices for popular procedures:
  1. Hemicolectomy
    ≈ $16,371
  2. Total colectomy
    ≈ $17,051
  3. Proctocolectomy
    ≈ $8,569
  4. Hartmann's operation
    ≈ $4,724
  5. Sigmoidectomy
    ≈ $9,092
  6. Rectum anterior resection
    ≈ $17,788
  7. Radiation therapy
    by request
  8. Intensity-modulated radiation therapy (IMRT)
    by request
  9. Chemotherapy for colorectal cancer
    by request
photo
Paris, France
Specializations: Thoracic surgery, Orthopedic surgery, Oncology
The Ambroise Paré, Pierre Cherest and Hartmann Clinics bring together specialized multidisciplinary teams. Regarding the financial aspect of care, every effort is made to ensure read more

Clinics grouping by rating

Clinic with the highest rating of 5 — Berkana clinic in Moscow, Russia and 4 more, clinic with the most reviews number of 35757 — Aster CMI hospital in Bengaluru, India.

With rating 4.0 and over — 305 clinics .

Countries with the highest number of clinics treating the diseases:

Colorectal cancer (CRC):

Related procedures:

Colorectal Cancer: Overview and Treatment Options

Colorectal Cancer – The Disease Explanation

Disease types & epidemiology

How common is the disease?

Colorectal or colon cancer is a disease in which cells in the large intestine grow out of control. Regardless of where the cancer started – in the colon or the rectum – tumors in these locations share a lot in common, which is why they’re together known as colorectal cancer. Colorectal cancer (CRC) predominantly develops as malignant tumors where cells are at first dividing on-site and then spreading in different tissues out of the intestine.

The variety of abnormal cells defines the colorectal cancer type. The most common – 95% - are adenocarcinomas, which arise from glandular epithelial cells. Typical adenocarcinoma takes at least ten years to develop from benign adenoma. However, about 15% of adenocarcinomas are more aggressive in two cases: mucinous adenocarcinoma – 10% of CRC – and signet ring cell adenocarcinoma – 1% of CRC. These tumors may spread rapidly within 2-3 years after appearing and are more challenging to treat.

Rare CRC types – less than 1 % of each kind – are:

  1. neurons-derived carcinoid tumors called Neuroendocrine Tumors (NET);
  2. lymphocyte-derived Non-Hodgkin Lymphoma;
  3. intestinal “pacemaker” cells of Cajal produce rare Gastrointestinal Stromal Tumors (GIST);
  4. “cancer of smooth muscle in rectum or colon” - Leiomyosarcoma;
  5. colon and rectal Melanomas from pigmental epithelial cells;
  6. colorectal squamous cell carcinoma;
  7. Familial Adenomatous Polyposis (FAP) – a specific inherited condition associated with massive large intestine polyposis from 10-12 years of age.

In the United States, there are 36.6 new cases of CRC per 100,000 men and women per year. According to the National Cancer Institute, about 4.1% of adults will be diagnosed with colorectal cancer at some point in their lifetime.

Causes & risk factors

What is the primary issue of colon cancer?

CRC includes 20-30% hereditary (FAP and Lynch syndrome) and 70-80% spontaneous cases.

The most common scenario for adenocarcinoma CRC development is when epithelial cells undergo a series of genetic or epigenetic changes that enable them to be hyperproliferative – grow fast and spread far. The cancer begins from a tiny benign adenoma in the colorectal segment of the intestine. During the next 10-15 years, under the influence of persistent chronic inflammation from carcinogens and mechanical defects, the adenoma may acquire some cellular damage via pathways of microsatellite instability (MSI) – in 20% of cases - and chromosomal instability (CIN) – 80%.

The cause of CRC is DNA mutations in the inner layer cells of the intestine. Under the influence of genetic damage, bowel epithelium grows uncontrollably. That is a transformation caused by the loss of the tumor suppressor gene APC, which leads tiny adenoma to grow into large but still benign one. Consequently, the activation of KRAS/ BRAF oncogenes and loss of tumor suppressor genes DCC and p53 open a gate of adenoma-to-adenocarcinoma transition through early and late adenoma stages to malignant tumor.

There are two groups of risk factors for the development of CRC: non-modifiable and modifiable. The first group cannot be controlled by individuals, while modifiable risk factors are related to individual habits or lifestyles.

Non-modifiable risk factors for CRC

· Age: most colorectal malignancies manifest at over 50 years. On average, spontaneous colon cancer occurs at 68 years in men and at 72 years in women, while rectal cancer – at 63 years in both genders. Familial forms of CRC develop early in life, with a mean age at diagnosis at roughly 45 years.

· Gender: males tend to be more likely to develop CRC, +87% risk vs women before age 49 and +44% over 50 years old.

· Ethnicity: black men and women have the highest incidence and mortality rates among races, followed by white race, Asians, and American Natives.

· Medical comorbidities: Inflammatory Bowel Disease in medical history triples the chance of developing CRC; with type 2 Diabetes Mellitus (DMt2) the CRC risk is shown to be approximately five times greater than in people with no DMt2.

· Family history of first-degree relatives with CRC is associated with almost two times higher risk compared to no CRC in family background.

· Untreated FAP (APC gene mutation) set 100% lifetime risk of CRC and Lynch syndrome (DNA MMR genes mutation) – 60% risk.

Modifiable risk factors for CRC

· Physical inactivity: an appropriate physical workout reduces the risk of CRC by 24%.

· Obesity: increasing body mass index (BMI) of every 8 kg/m<sup>2</sup> adds 10% CRC risk.

· Regular alcohol consumption: the risk of CRC rises by 21% with 2-4 drinks/day (moderate) and 52% with ≥4 drinks/day (heavy).

· Cigarette smoking: the risk increases by 6% for 5 pack-years up to 26% for 30 pack-years.

· Eating ≥500 g/week of processed and red meat (beef, pork, lamb) raises CRC risk by 20-30% due to the carcinogenic effects of heme iron molecules.

· People with normal high-fiber dietary patterns, such as vegetables, fruits, whole grains, and cereals, have a 14% decreased risk of CRC development. Conversely, a fiber deficit in consumed food is a moderate risk factor of CRC.

Clinical manifestation & symptoms

What signs should one anticipate while suspecting colorectal cancer?

Colon cancer doesn’t always cause symptoms, especially at first. That’s why screening for those over 45 years old is essential.

The initial symptoms may include:

  • a change in bowel habits, such as diarrhea, constipation, or feeling that the bowel does not empty all the way;
  • blood in bowel movement (stool);
  • frequent abdominal/pelvic pain, aches, or cramps;
  • weight loss without known reason.

Diagnostic route & screening

When, where, and how should colorectal cancer be detected?

Regular CRC screening begins for men and women aged 45 years in the U.S. and 50 in Europe. However, persons with familial history of CRC, genetic syndrome (FAP or Lynch syndrome), and inflammatory bowel disease (Crohn’s disease and ulcerative colitis) may proceed to the screening earlier than 45 years old.

The screening gives a person without colorectal tumor symptoms information on possible precancerous polyp so that it can be removed before turning into cancer. It includes:

  • guaiac-based fecal occult blood test (gFOBT) or the fecal immunochemical test (FIT) every 2 years – to identify if there is a silent bleeding from a damaged intestinal polyp;
  • flexible sigmoidoscopy or colonoscopy every 10 years – to visualize any possible benign adenoma or polyp in the gut.

The screening program is active to age 70-75 years.

If an adult doesn’t follow the screening but presents any symptoms of possible CRC, the tests mentioned above are provided by clinics as diagnostic methods. The diagnosed CRC is classified by the stage of progression and metastasis evidence: from stage 0 (intramucosal carcinoma) through stages I-IIB (the tumor grows into the intestinal wall), then stage IIC-III (the tumor growth into nearby organs by itself or/and spread to 1-7 nearby lymph nodes) and, finally, stage IV (tumor enters liver, lungs, or bones through metastasis).

About 80% of primary CRC diagnoses are patients with stage 0-III tumors, and the remaining 20% are stage IV cancer.

Treatment approaches

What are the options for managing colorectal cancer?

For those CRC lesions which reside locally without lymph nodes and distant organs involvement (stages 0-II), surgical resection of the tumor within a part of the intestine is the primary treatment option. The adjuvant fluorouracil-based (5-FU) chemotherapy for patients with CRC stage II and increased risk of recurrence [the involvement of visceral peritoneum or very abnormal histology] is an option.

Patients with CRC stage III are recommended to receive surgical treatment combined with adjuvant chemotherapy based on one of the following regimes:

  • fluorouracil/levamisole (5-FU/LV) OR capecitabine (weaker immunosuppressive adverse effect);
  • FOLFOX-4: oxaliplatin/5-FU/LV;
  • CAPOX: capecitabine/oxaliplatin.

Stage IV metastatic CRC (mCRC), due to the vast dissemination of secondary lesions, is operable only in 20% of patients whose tumors and metastases can be radically resected. For the rest of mCRC patients, the surgical approach is often combined with palliative chemotherapy to reduce the number and the volume of metastasis.

It is recommended to start with the first-line chemotherapy, such as 5-FU, capecitabine, irinotecan, oxaliplatin, FOLFOXIRI (irinotecan/oxaliplatin/LV/5-FU).

The response rate for the first-line drugs is around 50-54%, leaving roughly half of the patients as a second-line targeted therapy against different cellular factors that support tumor growth:

  • bevacizumab (anti-VEGF) combined with FOLFIRI or FOLFOX regime;
  • cetuximab (anti-EGFR) alone or combined with FOLFOX/bevacizumab – especially beneficial for KRAS mutation-negative mCRC patients;
  • panitumumab (anti-EGFR) combined with FOLFOX-4 – especially beneficial for KRAS mutation-negative mCRC patients;
  • aflibercept (anti-VEGF) combined with FOLFIRI;
  • ramucirumab (anti-VEGFr2) combined with FOLFIRI;
  • trifluridine-tipiracil combined with bevacizumab;
  • regorafenib (tyrosine kinase inhibitor);
  • encorafenib with cetuximab for BRAF V600E mutations-positive mCRC patients.

The second-line therapy is successful in 20-45% of first-line drug-resistant mCRC patients.

About 4% of mCRC patients have hereditary forms of the disease with specific mutations such as dMMR and MSI-H. For these patient subgroups, immunotherapies were invented. The following drugs are increasing the progression-free survival rate for patients twice better than standard chemotherapy: pembrolizumab (KRAS-negative tumors) and nivolumab/ipilimumab (KRAS-positive tumors).

Prognosis

How does cutting-edge science improve the lifespan and quality of life for those with the disease?

The 5-year relative survival rate for CRC patients is 65%, including 9 out 10 alive patients with stages 0-IIB and 7 out of 10 alive patients with stages IIC-III. The mCRC stage IV is a highly aggressive tumor, which gives a patient, on average, a 3-year 20% and 5-year 10% survival rate if left untreated.

The current diagnostic approach can detect only 40% of CRC cases in the early stages, and the condition might recur following surgery and adjuvant treatment. That’s why regular screening, detecting, and removing polyps at the early stage is crucial; thereby, CRC can be prevented.

Diagnostic & Treatment Management of Colorectal Cancer Disease

Algorithm of diagnosis

What evaluations do CRC patients undergo to identify the best treatment strategy?

It is crucial to understand – both for a patient and a physician – the stage and clinical presentation of the disease so patient treatment and support are of total value. Additionally, in women, the diagnostic algorithm helps to rule out the presence of synchronous breast, ovarian, and endometrial cancers.

The diagnostic interventions include:

  1. Clinical examination: includes palpation (touching) of the abdomen and rectal examination. By doing so, the doctor determines whether the tumor has caused the liver to enlarge and whether it has caused excess fluid in the abdomen, called ascites. The rectal examination serves to identify if there are any signs of blood in the area.
  2. Endoscopy: allows the doctor to inspect the interior of the bowel for abnormal formation or growths in the inner lining of the intestine using a fine-lighted tube with camera and biopsy tools. If any abnormal lesion is found, the doctor can take a piece of it for histopathological (microscopic) examination. Endoscopy can be performed in different areas, by inserting a short rectoscope, longer sigmoidoscope, or a flexible colonoscope to investigate a target part of the large intestine precisely and carefully. Tumors found within 15 cm of the anus are classified as rectal cancer, whereas any further away from the anus location are called colon tumors. When a rectal tumor is found during a rectoscopy, a complete colonoscopy is also required to check if the pathology resides locally or distributed through the gut.
  3. Radiological investigation: if the endoscopy is challenging to perform, for example, in obstructive tumors, a virtual colonoscopy may be an option. This examination involves a computer tomography (CT) scan of the abdomen, after which a computer produces 3-D images from the interior wall of the large intestine.

An outdated but occasionally used radiological option is a double contrast barium enema with barium sulfate (a chalky liquid commonly used in radiological examinations), and air are introduced into the colon via the anus, typically when the right-sided part of the colon is under investigation.

For the endoscopy and virtual colonoscopy, adequate bowel preparation is needed.

Additional radiological techniques may be used to determine the level of the tumor spread and the presence of metastases. They include a CT scan of the chest, ultrasound of the liver, and endoscopic ultrasound. While nuclear magnetic resonance imaging (MRI) of the rectum is a routine diagnostic procedure in rectal cancer, it stays optional in colon cancer. Positron emission tomography (PET) is another way to visualize metastasis in high resolution, but PET scans are not performed routinely due to their cost.

  1. Laboratory tests: routine blood sample measurements give information on complete blood count and liver/kidney function. Tumor markers monitoring helps to identify a level of a specific protein called carcinoembryonic antigen (CEA), which is sometimes elevated in this pathology. If CRC patients have high CEA levels at initial diagnosis, observing this marker level during and after treatment is wise.
  2. Histopathological examination: means laboratory investigation of the tumor tissue under a microscope on the biopsy or polyp obtained via endoscopy. As a result, the doctor will have information on specific mutations (such as RAS, BRAF, MLH1, CIN, MSI, etc.) within tumor cells sensitive to target therapy (molecular profiling). Also, the doctor performs histology-assessed tumor staging from 0 to IV, which helps to understand the disease's prognosis and possible regional or metastatic risk.

Treatment routes

What is an appropriate treatment for different CRC stages?

Surgery is the most effective one-step maneuver to treat CRC forms that have not spread to distant sites. Radiation therapy and/or chemotherapy may also be options for people who aren’t healthy enough for surgery or for when complete resection is not possible due to tumor location.

Treating stage 0 CRC

The stage 0 colon tumors have not grown beyond the inner lining of the colon. That is why surgery to take out the cancer via excision of the polyp (polypectomy) through the intestinal lumen (colonoscopy approach) is often the only treatment needed. This procedure is called endoscopic mucosal resection (EMR) or transanal minimally invasive surgery (TAMIS).

Treating stage I CRC

A more advanced surgical approach can be utilized when the cancer has grown deeper through the intestinal wall but has not spread outside the colon wall itself or into nearby lymph nodes. In the case of polyp-formed CRC stage I, the polypectomy (polyp removal) during colonoscopy via EMR or local excision with a small amount of surrounding healthy tissue on the colon wall via TAMIS is performed. If no cancer cells are at the edges (margins) of the removed piece, no other treatment may be needed.

However, there are following situations when surgical removing a small part of the colon (partial colectomy ≥ 5 cm on either side of the tumor) is a standard treatment in advanced CRC stage I:

  • if the tumor presents as high-grade (highly abnormal cells on histology),
  • if there are cancer cells at the edges of the polyp, or if the polyp couldn’t be removed completely,
  • if the polyp had to be removed in many pieces.

If only part of the colon is removed, it’s called a hemicolectomy, partial colectomy, or segmental resection. The surgeon takes out the part of the colon with the cancer and a small segment of the normal colon on either side. Usually, about one-fourth to one-third of the colon is removed, depending on the size and location of the cancer. A colectomy can be done in 2 ways:

  1. open colectomy when the surgery is done through a single long incision (cut) in the abdomen (belly);
  2. laparoscopic-assisted colectomy, also known as minimally invasive surgery - through 3-4 smaller incisions (0,5-2 cm length) in the belly with the use of special manipulation tools and a small camera. Due to minor body damage, patient recovery in this option is much faster, while overall survival rates and the chance of cancer returning are the same compared to open colectomy.

After the operation, the colon’s remaining sections are reattached in three ways: end-to-end, side-to-side (prevents lumen narrowing), or end-to-side (connects smaller lumen with the larger one). In the advanced CRC stage, end-to-end and side-to-side connections (anastomoses) are options of choice. At least 12 nearby lymph nodes are also removed so they can be checked for cancer.

Treating stage II CRC

The CRC at stage II penetrates the intestinal wall and may invade nearby tissue. Patients in this group receive surgery as a standard cure method - a partial colectomy along with nearby lymph nodes removal. Another name for this operation is En bloc colonic and mesentery resection since cancer lesions in the intestinal wall and infiltrated fat tissue are resected without breaking the tumor capsule.

Suppose the involved area is too large to perform an anastomosis on the resting bowel ends immediately after the resection. In that case, the surgeon will move one end of the intestine through an opening in the abdominal wall and connect it to a bag or pouch. This is called colostomy and it’s done so that stools that would normally move through the intestine to the rectum instead pass through the opening in the abdomen into the pouch. The colostomy bag must be manually emptied. The colostomy is often only used as a short-term solution and consequently is replaced by ileocolonic anastomosis, which re-connects the small intestine and colon.

If a CRC stage II tumor looks very abnormal when viewed closely in the lab, or it has grown into nearby blood or lymph nodes, or there is a blocked (obstructed) lumen / perforated (hole) colon wall, the neoadjuvant chemotherapy for 3-6 months is recommended, including capecitabine or fluoropyrimidine (5-FU) treatment.

The medication treatment starts as adjuvant therapy within eight weeks after the surgery at stages II-IV, when the tumor can involve the whole depth of the bowel, raising intestine wall perforation awareness.

Treating stage III CRC

Stage III colon cancer is widespread to nearby lymph nodes, which is why surgeons often perform partial colectomy, followed by 3-6 months adjuvant treatment (5-FU, oxaliplatin, capecitabine) to prevent further spreading of the disease without mutations dMMR or MSI-H. If these mutations appear, neoadjuvant immunotherapy (pembrolizumab, etc.) is recommended.

Radiation therapy may accompany the surgery when some advanced stage III tumors are found to be attached to a nearby organ:

  • before the surgery, radiation therapy helps to shrink a tumor and make it easier to remove;
  • after the surgery - double-check for cancer cell killing in a region;
  • during the surgery - intraoperative radiation therapy (IORT) - to clean the area from possible tumor cells left.
Treating stage IV CRC

The challenge with terminal stage IV CRC is that it is a metastatic tumor (mCRC) that involves the liver, lungs, and bones. That’s why the surgery bears only a palliative goal, meaning the partial colectomy or the total colectomy (removing all the colon) would not have a decisive effect on the patient’s recovery.

The number of operable cases in CRC decreases with stage growth. Starting from stage I CRC– about 90% of patients are surgery-eligible - to metastatic CRC (mCRC) stage IV, where due to comorbidities, there is about a 20% chance to be eligible for radical surgery.

At CRC stage IV, radiation therapy, chemotherapy, and immunotherapy are the first-line treatments.

Radiation therapy includes three types:

  1. External-beam radiation therapy (EBRT) - helps to focus the radiation beam on the cancer from a machine outside the body. There are techniques, such as three-dimensional conformal radiation therapy (3D-CRT), intensity modulated radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT), have been shown to treat lungs and liver CRC metastases;
  2. Internal radiation therapy (brachytherapy) - treats rectal cancer since the radiation source is put inside the rectum next to or into the tumor;
  3. Radioembolization - means injecting tiny beads (called microspheres) coated with radioactive yttrium-90 (Y-90) into the hepatic artery. The beads lodge in the blood vessels near the metastasis in the liver, where they give off small amounts of radiation to the tumor site for several days.

Chemotherapy treatment of peritoneum (inner wall of the abdomen) metastatic lesions in mCRC includes:

  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC) uses high-concentration drug mitomycin-C combined with hyperthermia 39-43°C and high-pressure flow;
  • Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) uses high pressure to push chemo drug (oxaliplatin) into metastatic cells.

Mutation-specific approach for CRC (immunotherapy)

Are there any personalized medicine options?

A few options for standard treatment-resistant mutation-based personalized approach as a first-line therapy were developed in the last decade. The immunotherapy drugs (bevacizumab, cetuximab, panitumumab, etc.) target specific molecular proteins from a group called Growth Factors, which provide cancer rapid growth and spread when genetic mutations trigger its overproduction. The medications block the ability of cells to produce the growth factors, thus shrinking the tumor.

Follow-up & surveillance strategy

How do you make sure the cancer will not return?

Monitoring of CRC blood markers such as carcinoembryonic antigen (CEA) may help to catch a cancer recurrence after initial treatment at an early stage.

Localized Colon Cancer stage 0-III surveillance program:

  • when surgery is not possible due to significant comorbidities, surveillance colonoscopy within six months after polyp removal with close oncological follow-up, including a CT scan to detect lymph node recurrences, is recommended;
  • if the surgery went successfully, repeat colonoscopy in 1-2 years and 3-5 years thereafter;
  • CEA determination and physical examination every 3-6 months for three years and every 6-12 months at years 4 and 5 after surgery;
  • CT scans of the chest and abdomen every 6-12 months for the first three years for high-risk recurrence stage II-III CRC patients.

Metastatic Colon Cancer stage III-IV surveillance program:

  • for patients receiving active treatment, a CT scan or MRI plus CEA measurement every 8-12 weeks is recommended;
  • after radically resected metastatic disease – CT or MRI plus CEA levels every three months during the first two years and every six months thereafter.
  • Isabella Gonzalez, M.D.
Show less

Related video